Study Design Considerations Research protocols must specify exact dosing schedules and concentrations
The article names severe upper abdominal pain radiating to the back as a sign of possible acute pancreatitis, along with persistent severe vomiting, vision changes, and signs of hypoglycemia in insulin-treated patients
doi: 10.1007/s11154-021-09699-1
Description Product Information Product Name: Retatrutide (LY3437943), 99.70% purity peptide (TFA removed) Description: Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors (3G) , the EC50 values are 5.79 nM, 0.0643 nM, and 0.775 nM respectively [1]
It is interesting to note that the positive effect of tirzepatide on body weight is associated with a significant improvement in quality of life and physical performance [50] and is independent of sex [51], baseline body mass index (BMI) [52] and potential side effects, predominantly gastrointestinal [53]
This product should be kept in the original bottle, tightly closed with the original desiccant remaining in the bottle.